Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05353439 |
|---|---|
| Brief Title: | Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer |
| First Submitted : | April 23, 2022 |
| First Submitted that Met QC Criteria : | April 23, 2022 |
| First Posted : | April 29, 2022 |
| Last Update Submitted that Met QC Criteria : | March 7, 2023 |
| Last Update Posted : | March 8, 2023 |